• Je něco špatně v tomto záznamu ?

Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation

Z. Stejskalova, Z. Rohan, R. Rusina, A. Tesar, J. Kukal, GG. Kovacs, A. Bartos, R. Matej,

. 2019 ; 19 (1) : 42. [pub] 20190320

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19027703

Grantová podpora
VFN64165 Ministerstvo Zdravotnictví Ceské Republiky
TN64190 Thomayer hospital
Q27/LF1 Univerzita Karlova v Praze
Q28/LF1 Univerzita Karlova v Praze
Q35/LF3 Univerzita Karlova v Praze
GAUK 113115 Univerzita Karlova v Praze
NPU I LO1611 Ministerstvo Školství, Mládeže a Tělovýchovy
AVASTipendium Czech Alzheimer Foundation and AVAST!

BACKGROUND: We aimed to produce a detailed neuropathological analysis of pyramidal motor system pathology and provide its clinical pathological correlation in cases with definite progressive supranuclear palsy (PSP). METHODS: Pyramidal motor system pathologies were analyzed in 18 cases with neuropathologically confirmed PSP. Based on a retrospective clinical analysis, cases were subtyped according to Movement Disorder Society criteria for clinical diagnosis of PSP as probable, possible or suggestive of PSP with Richardson's syndrome (n = 10), PSP with predominant corticobasal syndrome (n = 3), PSP with predominant parkinsonism (n = 3), PSP with predominant speech/language disorder (n = 1), and PSP with progressive gait freezing (n = 1). Clinical manifestations of motor neuron involvement (pseudobulbar or bulbar signs and spasticity) were retrospectively assessed semiquantitatively. Neuropathologically, hyperphosphorylated tau-related pyramidal motor system neuronal, neuritic, and glial pathology using anti-tau AT8 clone immunohistochemistry, was also evaluated. RESULTS: Clinical manifestations of pyramidal motor system involvement were found in patients with different PSP subtypes. A statistically significant higher load of tau pathology was found in the pyramidal system in PSP-Richardson's syndrome compared to other PSP subtypes (p = 0.016); however, there was no significant correlation between pyramidal system tau pathology and related motor clinical symptoms. CONCLUSIONS: Tau pathology in the spinal cord and pyramidal motor system structures is very common in progressive supranuclear palsy and may neuropathologically supplement the distinction between classic Richardson's syndrome from other progressive supranuclear palsy subtypes.

Department of Neurology and Center of Clinical Neuroscience 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

Department of Neurology and Center of Clinical Neuroscience 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic Department of Neurology 3rd Faculty of Medicine Charles University and Thomayer Hospital Prague Czech Republic

Department of Pathology and Molecular Medicine 3rd Faculty of Medicine Charles University and Thomayer Hospital Videnska 800 14059 Prague 4 Krc Czech Republic Department of Pathology 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

Department of Pathology and Molecular Medicine 3rd Faculty of Medicine Charles University and Thomayer Hospital Videnska 800 14059 Prague 4 Krc Czech Republic Department of Pathology 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic Department of Pathology 3rd Faculty of Medicine Charles University and University Hospital Kralovske Vinohrady Prague Czech Republic

Department of Pathology and Molecular Medicine 3rd Faculty of Medicine Charles University and Thomayer Hospital Videnska 800 14059 Prague 4 Krc Czech Republic Department of Pathology 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic Department of Pathology 3rd Faculty of Medicine Charles University and University Hospital Kralovske Vinohrady Prague Czech Republic Department of Neurology and Center of Clinical Neuroscience 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

Faculty of Nuclear Sciences and Physical Engineering Czech Technical University Prague Czech Republic

Institute of Neurology General Hospital and Medical University of Vienna Vienna Austria

National Institute of Mental Health Klecany Czech Republic Department of Neurology 3rd Faculty of Medicine Charles University and University Hospital Kralovske Vinohrady Prague Czech Republic

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19027703
003      
CZ-PrNML
005      
20190822085352.0
007      
ta
008      
190813s2019 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12883-019-1270-1 $2 doi
035    __
$a (PubMed)30894142
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Stejskalova, Zuzana $u Department of Pathology and Molecular Medicine Third Faculty of Medicine, Charles University and Thomayer Hospital, Videnska 800, 14059, Prague 4 - Krc, Czech Republic. Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic. Department of Pathology, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic.
245    10
$a Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation / $c Z. Stejskalova, Z. Rohan, R. Rusina, A. Tesar, J. Kukal, GG. Kovacs, A. Bartos, R. Matej,
520    9_
$a BACKGROUND: We aimed to produce a detailed neuropathological analysis of pyramidal motor system pathology and provide its clinical pathological correlation in cases with definite progressive supranuclear palsy (PSP). METHODS: Pyramidal motor system pathologies were analyzed in 18 cases with neuropathologically confirmed PSP. Based on a retrospective clinical analysis, cases were subtyped according to Movement Disorder Society criteria for clinical diagnosis of PSP as probable, possible or suggestive of PSP with Richardson's syndrome (n = 10), PSP with predominant corticobasal syndrome (n = 3), PSP with predominant parkinsonism (n = 3), PSP with predominant speech/language disorder (n = 1), and PSP with progressive gait freezing (n = 1). Clinical manifestations of motor neuron involvement (pseudobulbar or bulbar signs and spasticity) were retrospectively assessed semiquantitatively. Neuropathologically, hyperphosphorylated tau-related pyramidal motor system neuronal, neuritic, and glial pathology using anti-tau AT8 clone immunohistochemistry, was also evaluated. RESULTS: Clinical manifestations of pyramidal motor system involvement were found in patients with different PSP subtypes. A statistically significant higher load of tau pathology was found in the pyramidal system in PSP-Richardson's syndrome compared to other PSP subtypes (p = 0.016); however, there was no significant correlation between pyramidal system tau pathology and related motor clinical symptoms. CONCLUSIONS: Tau pathology in the spinal cord and pyramidal motor system structures is very common in progressive supranuclear palsy and may neuropathologically supplement the distinction between classic Richardson's syndrome from other progressive supranuclear palsy subtypes.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a mozková kůra $x patologie $7 D002540
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a imunohistochemie $7 D007150
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a pohybové poruchy $x diagnóza $x patologie $7 D009069
650    _2
$a parkinsonské poruchy $x diagnóza $x patologie $7 D020734
650    _2
$a pyramidové dráhy $x patologie $7 D011712
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a progresivní supranukleární obrna $x diagnóza $x patologie $7 D013494
650    _2
$a proteiny tau $x metabolismus $7 D016875
655    _2
$a časopisecké články $7 D016428
700    1_
$a Rohan, Zdenek $u Department of Pathology and Molecular Medicine Third Faculty of Medicine, Charles University and Thomayer Hospital, Videnska 800, 14059, Prague 4 - Krc, Czech Republic. zdenek.rohan@hotmail.com. Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic. zdenek.rohan@hotmail.com.
700    1_
$a Rusina, Robert $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic. Department of Neurology Third Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic.
700    1_
$a Tesar, Adam $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
700    1_
$a Kukal, Jaromir $u Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University, Prague, Czech Republic.
700    1_
$a Kovacs, Gabor G $u Institute of Neurology, General Hospital and Medical University of Vienna, Vienna, Austria.
700    1_
$a Bartos, Ales $u National Institute of Mental Health, Klecany, Czech Republic. Department of Neurology, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic.
700    1_
$a Matej, Radoslav $u Department of Pathology and Molecular Medicine Third Faculty of Medicine, Charles University and Thomayer Hospital, Videnska 800, 14059, Prague 4 - Krc, Czech Republic. Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic. Department of Pathology, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic. Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
773    0_
$w MED00008195 $t BMC neurology $x 1471-2377 $g Roč. 19, č. 1 (2019), s. 42
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30894142 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190822085630 $b ABA008
999    __
$a ok $b bmc $g 1432852 $s 1066163
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 19 $c 1 $d 42 $e 20190320 $i 1471-2377 $m BMC neurology $n BMC Neurol $x MED00008195
GRA    __
$a VFN64165 $p Ministerstvo Zdravotnictví Ceské Republiky
GRA    __
$a TN64190 $p Thomayer hospital
GRA    __
$a Q27/LF1 $p Univerzita Karlova v Praze
GRA    __
$a Q28/LF1 $p Univerzita Karlova v Praze
GRA    __
$a Q35/LF3 $p Univerzita Karlova v Praze
GRA    __
$a GAUK 113115 $p Univerzita Karlova v Praze
GRA    __
$a NPU I LO1611 $p Ministerstvo Školství, Mládeže a Tělovýchovy
GRA    __
$a AVASTipendium $p Czech Alzheimer Foundation and AVAST!
LZP    __
$a Pubmed-20190813

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...